Literature DB >> 16510452

Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia.

J Rello1, A Rodriguez, A Torres, J Roig, J Sole-Violan, J Garnacho-Montero, M V de la Torre, J M Sirvent, M Bodi.   

Abstract

The mortality rate of chronic obstructive pulmonary disease (COPD) patients with community-acquired pneumonia (CAP) is reported to be low. However, studies carried out to date have included <20% of critically ill patients. The current authors performed a secondary analysis of a prospective study evaluating 428 immunocompetent patients admitted to the intensive care unit (ICU) for severe CAP. In total, 176 COPD patients were compared with 252 non-COPD patients. In COPD patients, ICU mortality (odds ratio (OR) 1.58; 95% confidence interval (CI) 1.01-1.43) and mechanical ventilation (OR 2.78; 95% CI 1.63-4.74) rates were higher than in non-COPD patients. The ICU mortality was 39% for COPD patients initially intubated and 50% for those who failed noninvasive ventilation. The proportion of patients who were males, aged >/=70 yrs, smokers and who had chronic heart disease or Pseudomonas aeruginosa were higher in COPD patients. Inappropriate empirical antibiotic therapy was associated with higher mortality (OR 3.8; 95% CI 1.19-12.6). ICU mortality in COPD patients with adequate therapy was associated with bilateral pneumonia (OR 2.32; 95% CI 1.18-4.53) and shock (OR 3.53; 95% CI 1.31-9.71). In conclusion, chronic obstructive pulmonary disease patients hospitalised with community-acquired pneumonia in the intensive care unit had higher mortality and need of mechanical ventilation when compared with patients without chronic obstructive pulmonary disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16510452     DOI: 10.1183/09031936.06.00139305

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  39 in total

1.  Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia.

Authors:  Dennis Chen; Marcos I Restrepo; Michael J Fine; Mary Jo V Pugh; Antonio Anzueto; Mark L Metersky; Brandy Nakashima; Chester Good; Eric M Mortensen
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

2.  Increased Severity and Mortality of CAP in COPD: Results from the German Competence Network, CAPNETZ.

Authors:  Dionne C W Braeken; Frits M E Franssen; Hartwig Schütte; Mathias W Pletz; Robert Bals; Peter Martus; Gernot G U Rohde
Journal:  Chronic Obstr Pulm Dis       Date:  2015-03-26

Review 3.  Inhaled corticosteroids and the increased risk of pneumonia: what's new? A 2015 updated review.

Authors:  Hernan Iannella; Carlos Luna; Grant Waterer
Journal:  Ther Adv Respir Dis       Date:  2016-02-18       Impact factor: 4.031

4.  Thin-section CT findings in Pseudomonas aeruginosa pulmonary infection.

Authors:  F Okada; A Ono; Y Ando; T Nakayama; R Ishii; H Sato; A Kira; I Tokimatsu; J Kadota; H Mori
Journal:  Br J Radiol       Date:  2012-07-27       Impact factor: 3.039

5.  Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era.

Authors:  Isaline Coquet; Juliette Pavie; Pierre Palmer; François Barbier; Stéphane Legriel; Julien Mayaux; Jean Michel Molina; Benoît Schlemmer; Elie Azoulay
Journal:  Crit Care       Date:  2010-06-09       Impact factor: 9.097

6.  Early fiberoptic bronchoscopy during non-invasive ventilation in patients with decompensated chronic obstructive pulmonary disease due to community-acquired-pneumonia.

Authors:  Raffaele Scala; Mario Naldi; Uberto Maccari
Journal:  Crit Care       Date:  2010-04-29       Impact factor: 9.097

7.  Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality.

Authors:  Marcos I Restrepo; Eric M Mortensen; Jordi Rello; Jennifer Brody; Antonio Anzueto
Journal:  Chest       Date:  2009-10-31       Impact factor: 9.410

8.  Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia.

Authors:  Oriol Sibila; Eric M Mortensen; Antonio Anzueto; Elena Laserna; Marcos I Restrepo
Journal:  Eur Respir J       Date:  2013-04-18       Impact factor: 16.671

9.  Mortality of COPD patients infected with multi-resistant Pseudomonas aeruginosa: a case and control study.

Authors:  M Montero; M Domínguez; M Orozco-Levi; M Salvadó; H Knobel
Journal:  Infection       Date:  2008-12-05       Impact factor: 3.553

10.  COPD patients with ventilator-associated pneumonia: implications for management.

Authors:  D Koulenti; S Blot; J M Dulhunty; L Papazian; I Martin-Loeches; G Dimopoulos; C Brun-Buisson; M Nauwynck; C Putensen; J Sole-Violan; A Armaganidis; J Rello
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-25       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.